Elizabeth E. Powell
About
In The Last Decade
Elizabeth E. Powell
203 papers receiving 13.5k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Epidemiology 9.3k
- Hepatology 6.6k
- Endocrinology, Diabetes and Metabolism 2.5k
- Surgery 1.9k
- Molecular Biology 1.8k
Countries citing papers authored by Elizabeth E. Powell
This map shows the geographic impact of Elizabeth E. Powell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth E. Powell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth E. Powell more than expected).
Fields of papers citing papers by Elizabeth E. Powell
This network shows the impact of papers produced by Elizabeth E. Powell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth E. Powell. The network helps show where Elizabeth E. Powell may publish in the future.
Co-authorship network of co-authors of Elizabeth E. Powell
This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth E. Powell. A scholar is included among the top collaborators of Elizabeth E. Powell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth E. Powell. Elizabeth E. Powell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 8 | |
| 6 | 5 | |
| 7 | 5 | |
| 8 | 5 | |
| 9 | 13 | |
| 10 | 10 | |
| 11 | 35 | |
| 12 | 22 | |
| 13 | Patterns of service utilisation within hepatology clinics: high prevalence of advanced liver disease | 1 |
| 14 | Blocking Wnt protein secretion from macrophages exacerbates liver fibrosis and hepatic progenitor cell activation | 1 |
| 15 | Economic consideration for reducing hospital presentations among patients with decompensated cirrhosis: not all presentations avoided can be considered equal | 1 |
| 16 | Predicting clinical outcomes in chronic liver disease: the ELF test is superior to histology and simple scores | 1 |
| 17 | Discrepancies in the use of medications in patients with cirrhosis | 1 |
| 18 | Microbial burden is associated with clinical outcomes and reduced ascites innate immune cells in non-infected ascites | 1 |
| 19 | Assessment of alcohol histories obtained from patients with liver disease: Opportunities to improve early intervention | 0 |
| 20 | Fibrosis in chronic hepatitis C correlates significantly with circulating C-peptide and insulin levels | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.